Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NKX2-2 | hg38_v1_chr20_-_21514046_21514070 | 0.27 | 1.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_16600703 Show fit | 2.59 |
ENST00000616247.4
|
LIM domain only 3 |
|
chr2_+_102337148 Show fit | 2.16 |
ENST00000311734.6
ENST00000409584.5 |
interleukin 1 receptor like 1 |
|
chr3_+_159273235 Show fit | 1.90 |
ENST00000638749.1
|
IQCJ-SCHIP1 readthrough |
|
chr3_-_33645433 Show fit | 1.65 |
ENST00000635664.1
ENST00000485378.6 ENST00000313350.10 ENST00000487200.5 |
cytoplasmic linker associated protein 2 |
|
chrX_+_136205982 Show fit | 1.48 |
ENST00000628568.1
|
four and a half LIM domains 1 |
|
chr16_+_23182737 Show fit | 1.47 |
ENST00000300061.3
|
sodium channel epithelial 1 subunit gamma |
|
chr2_+_79120474 Show fit | 1.46 |
ENST00000233735.2
|
regenerating family member 1 alpha |
|
chr7_+_97732046 Show fit | 1.31 |
ENST00000350485.8
ENST00000346867.4 ENST00000319273.10 |
tachykinin precursor 1 |
|
chrX_+_106201724 Show fit | 1.28 |
ENST00000372552.1
|
PWWP domain containing 3B |
|
chrX_+_153687918 Show fit | 1.26 |
ENST00000253122.10
|
solute carrier family 6 member 8 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.7 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.3 | 2.6 | GO:0097338 | response to clozapine(GO:0097338) |
0.2 | 2.6 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 2.5 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.3 | 2.2 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.1 | 2.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 2.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 2.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 1.8 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
0.4 | 1.7 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 2.7 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 2.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 2.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 2.4 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 2.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 2.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 2.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 1.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.8 | GO:0016580 | Sin3 complex(GO:0016580) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 3.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 2.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 2.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 2.4 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 2.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.7 | 2.2 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.3 | 2.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 1.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 1.8 | GO:0008565 | protein transporter activity(GO:0008565) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 4.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 3.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 2.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 1.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 1.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 1.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 1.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 1.3 | PID PLK1 PATHWAY | PLK1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.6 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 3.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 2.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 2.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 1.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 1.6 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 1.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 1.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |